UNSPSC 50501514: Choline

This classification denotes a water-soluble vitamin with the molecular formula C5H14NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N91BDP6H0X, chemically known as 2-hydroxy-n,n,n-trimethylethanaminium but more generally known as choline, which bears U.S. National Institutes of Health Compound Identifier 305. The European Medicines Agency schedules Choline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13349MIG.

CHOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OCC[N](C)(C)C

UNSPSC 50501514 Choline is a Commodity code that in recent state and local practice encompasses pharmaceutical and medical supply procurement, including naloxone and drug deactivation systems purchased by county health and emergency response agencies. Seminole County, Florida's June 2026 IFB for naloxone and safe drug deactivation systems illustrates the actual scope under this code: the county is procuring 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The work involves competitive bidding on fixed-fee contracts with standard compliance requirements, including drug-free workplace certification, E-Verify compliance, and specified insurance coverage (workers' compensation, commercial general liability, professional liability). Contractors bear shipping and delivery costs, and the contract carries an initial two-year term with a one-year renewal option and a three-month probationary termination clause. The procurement is potentially FEMA-funded, introducing adherence to federal environmental regulations such as the Clean Air Act and Federal Water Pollution Control Act.

The code shows limited recent documented activity in state and local procurement. The Seminole County opportunity represents the primary visible example, and characterization of broad geographic spread or a diverse issuing-body mix is not supported by the available data. Vendors pursuing this code should track county-level health departments and emergency response agencies in Florida and monitor for similar pharmaceutical and medical supply solicitations from other county and municipal health authorities, as naloxone and harm-reduction supply procurement has grown in visibility within county budgeting since 2023.